About this trial
This pilot study will be testing the feasibility of medical hypnosis through virtual reality during invasive médical procédures in children and young adults with cancer. Patients age from 7 to under 25 years whose treatement protocols required a lumbure puncture and a chemotherapy by implantable venous access will be randomly assigned to virtual reality or treatement as usual (nitrous oxide, anxiolytics, opioid analgesics, psychotropic and benzodiazepine). We expect the same benefit by using VR as usual intervention.
Eligibility criteria
Qualifiers
Patients aged 7 to strictly under 25
Follow-ups for hematological or oncological pathology
With a lumbar puncture or to connection to an implantable chamber
Patient understanding French
Disqualifiers
Children with cognitive impairment
Children in absolute emergency situations
Children with a contraindication to a virtual reality headset (psychiatric pathology, vestibular and proprioceptive disorders, unbalanced epilepsy, impaired vision, hearing aids, claustrophobia, recent lesions of the eyes, face or scalp)
Children who have already participated in the clinical investigation
Trial design
Treatments tested in this trial
- Virtual Reality
- Usual Practices